Clinical Trial Update: Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of low-dose levetiracetam on clinical symptoms, cognition, and hippocampal activity in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Schizophrenia | NA | Status: COMPLETED